Cookie Consent: We use cookies to give you the best online experience, for analytics, performance, and to tailor the experience towards your interests.

Skip to content
Pic of DealMakers: Entrepreneur | Startups | Venture Capital

Peter Donnelly: From Professor To Entrepreneur And Raising $100 Million To Prevent Diseases Like Cancer Entirely

June 29, 2021
0 comments

DealMakers: Entrepreneur | Startups | Venture Capital

Description

After many years of research, Sir Peter Donnelly made the leap from academia to founding his own company, to lead the charge in having a truly tangible impact with everything we are learning about genetics. His venture, Genomics PLC, has acquired funding from top-tier investors like F-Prime Capital, Oxford Sciences Innovation, Foresite Capital, and Lansdowne Partners.

In this episode, you will learn:

* Learning to love the journey and learning itself
* His outlook on COVID and other pandemics
* The great progress being made in genetics for combating serious diseases



Alejandro Cremades · EP 350 Peter Donnelly: From Professor To Entrepreneur And Raising $100 Million To Prevent Diseases
SUBSCRIBE ON:

For a winning deck, take a look at the pitch deck template created by Silicon Valley legend, Peter Thiel (see it here) that I recently covered. Thiel was the first angel investor in Facebook with a $500K check that turned into more than $1 billion in cash.




*FREE DOWNLOAD*
The Ultimate Guide To Pitch Decks







Moreover, I also provided a commentary on a pitch deck from an Uber competitor that has raised over $400 million (see it here).

Remember to unlock for free the pitch deck template that is being used by founders around the world to raise millions below.


About Sir Peter Donnelly:
Peter Donnelly is Director of the Wellcome Trust Centre for Human Genetics and Professor of Statistical Science at the University of Oxford, and a founder and director of Genomics plc, a fast-growing company in the genome analytics space.

He has played a leading role in many of the major projects and developments at the interface between genetics, healthcare, and clinical medicine, including the HapMap project, the Wellcome Trust Case Control consortia, and WGS500, one of the studies pioneering whole-genome sequencing in clinical medicine.





.alg-cta-consulting {
grid-template-columns: minmax(-webkit-min-content,-webkit-max-content) 1fr;
grid-template-columns: minmax(min-content,max-content) 1fr;;
}